March 22, 2011Open Access

Dalteparin versus Unfractionated Heparin in Critically Ill Patients

Key Points

Key points are not available for this paper at this time.

Abstract

Among critically ill patients, dalteparin was not superior to unfractionated heparin in decreasing the incidence of proximal deep-vein thrombosis. (Funded by the Canadian Institutes of Health Research and others; PROTECT ClinicalTrials.gov number, NCT00182143.).

Read Full Paperexternally

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

D’Arcy Duquette (Tue,) studied this question.

synapsesocial.com/papers/69d806aa45af6083e6ae2a33 https://doi.org/https://doi.org/10.1056/nejmoa1014475

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1NATURAL HISTORY OF POSTOPERATIVE DEEP-VEIN THROMBOSIS1969 · 904 citations
2Users' guides to the medical literature : a manual for evidence-based clinical practice2002 · 1,192 citations
3High risk of the critically ill for venous thromboembolism1982 · 283 citations
4Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples1977 · 8,407 citations
5Adjudicating Bleeding Outcomes in a Large Thromboprophylaxis Trial in Critical Illness.2009 · 5 citations

Perguntar à IA

Bookmark

View Full Paper